Nuveen Asset Management

Nuveen Asset Management Portfolio holdings

AUM $354B
1-Year Return 34.48%
 

Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.

This Quarter Return
-14.96%
1 Year Return
+34.48%
3 Year Return
+60.43%
5 Year Return
+189.89%
10 Year Return
+390.34%
AUM
$259B
AUM Growth
-$50.1B
Cap. Flow
-$2.37B
Cap. Flow %
-0.92%
Top 10 Hldgs %
21.65%
Holding
3,565
New
266
Increased
1,459
Reduced
1,410
Closed
322

Top Sells

1
BIDU icon
Baidu
BIDU
$302M
2
CSCO icon
Cisco
CSCO
$286M
3
ABBV icon
AbbVie
ABBV
$261M
4
NVDA icon
NVIDIA
NVDA
$210M
5
GM icon
General Motors
GM
$210M

Sector Composition

1 Technology 23.58%
2 Healthcare 13.98%
3 Financials 12.35%
4 Consumer Discretionary 10.53%
5 Industrials 8.28%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SPRU icon
3301
Spruce Power Holding Corp
SPRU
$27.3M
-84,557
Closed -$1.49M
SPRY icon
3302
ARS Pharmaceuticals
SPRY
$995M
-64,723
Closed -$272K
STIM icon
3303
Neuronetics
STIM
$214M
-79,147
Closed -$264K
STTK icon
3304
Shattuck Labs
STTK
$74.2M
-71,566
Closed -$346K
STXS icon
3305
Stereotaxis
STXS
$264M
-184,233
Closed -$688K
SYRE icon
3306
Spyre Therapeutics
SYRE
$1.03B
-6,765
Closed -$425K
TCRT icon
3307
Alaunos Therapeutics
TCRT
$4.27M
-18,630
Closed -$2.04M
TERN icon
3308
Terns Pharmaceuticals
TERN
$632M
-14,237
Closed -$43K
TNXP icon
3309
Tonix Pharmaceuticals
TNXP
$233M
-2
Closed -$315K
TOON icon
3310
Kartoon Studios
TOON
$38.5M
-108,412
Closed -$965K
TRDA icon
3311
Entrada Therapeutics
TRDA
$201M
-13,872
Closed -$130K
TSAT icon
3312
Telesat
TSAT
$342M
-31,999
Closed -$602K
TSHA icon
3313
Taysha Gene Therapies
TSHA
$917M
-105,426
Closed -$665K
TXMD icon
3314
TherapeuticsMD
TXMD
$12.5M
-21,234
Closed -$419K
UAVS icon
3315
AgEagle Aerial Systems
UAVS
$63M
-297
Closed -$332K
UL icon
3316
Unilever
UL
$158B
-13,892
Closed -$633K
URGN icon
3317
UroGen Pharma
URGN
$873M
-94,660
Closed -$854K
UXIN
3318
Uxin Ltd
UXIN
$722M
-2,393
Closed -$244K
VATE icon
3319
INNOVATE Corp
VATE
$75.2M
-15,593
Closed -$592K
VHC icon
3320
VirnetX
VHC
$78.5M
-12,610
Closed -$479K
VKTX icon
3321
Viking Therapeutics
VKTX
$3.03B
-263,132
Closed -$855K
VOR icon
3322
Vor Biopharma
VOR
$248M
-55,296
Closed -$422K
VRA icon
3323
Vera Bradley
VRA
$60.6M
-106,512
Closed -$869K
VRCA icon
3324
Verrica Pharmaceuticals
VRCA
$48.3M
-3,279
Closed -$277K
VRM icon
3325
Vroom, Inc. Common Stock
VRM
$140M
-4,874
Closed -$1.07M